MDMA’s 2021 FDA Forum

Registration is now open for MDMA’s 2021 FDA Forum (held virtually). Designed specifically for medical device regulatory professionals and executive decision makers, this conference will deliver key regulatory insights and preview trends that will impact your regulatory and business strategies.

CDRH Office of Product Evaluation and Quality (OPEQ) Director, William Maisel, is already confirmed for MDMA’s 2021 FDA Forum which will feature a number of senior officials from FDA and industry. This event will focus on the critical regulatory issues impacting the medical devices industry.

Topics will Include:

• FDA’s Response During COVID-19
• Navigating 510(k), De Novo & PMA Programs
• Digital Health
• CDRH Update
• Best Practices for Pre-submission Meetings
• Priorities from the New Administration

MDMA Members – $395

State Member – $495

Non-Members – $595

Georgia Bio Members can use discount code STATE to receive $100 off the nonmember rate.